HEALTHCARE & MEDICARE
-
Centene CEO: ICHRA is the future of personal health insurance
Individual Insurance Health Reimbursement Arrangements (ICHRAs) are growing, but relatively slowly. They allow employers to provide tax-free funds to employees…
Read More » -
Is Optum real?
At this week's annual HLTH conference in Las Vegas, UnitedHealth Group's data analytics subsidiary Optum announced the launch of Optum…
Read More » -
Technology Evolution: Why Clinicians Must Expand Data Sources
As a doctor, I have a confession to make. During a typical patient-physician encounter, we discuss the patient's health concerns,…
Read More » -
CMS’s new $50B rural health fund — is it just another Band-Aid?
With $50 billion set to flow to states over the next five years, CMS's new Rural Health Transformation Initiative is…
Read More » -
Who should be involved in conversations about women’s health?
Women's health was a major topic at the HLTH conference in Las Vegas on Monday. During the panel discussion, moderator…
Read More » -
Takeda inks $1.2B deal for Innovent cancer drug, boosting pipeline and revenue growth prospects
Takeda Pharmaceuticals is beefing up its pipeline in a big way, committing $1.2 billion to buy the rights to two…
Read More » -
There's no place like home – improving pediatric cardiac care outcomes and reducing recovery time
As healthcare providers, we often ask ourselves what true success looks like for our patients. In the increasingly complex world…
Read More » -
Hyro secures $45M for its conversational AI agent
Agentic AI company Hyro closed a $45 million round of funding led by Healthier Capital on Tuesday, bringing its total…
Read More » -
AMA launches center for digital health and artificial intelligence to boost physician voice in technology
The use of artificial intelligence in healthcare is growing rapidly, but doctors are often left out of discussions about how…
Read More » -
Galapagos Islands to halt cell therapy business after finding buyer to no avail
Galapagos reversed course earlier this year, announcing it would no longer focus on cell therapies and would seek a buyer…
Read More »